KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bausch Health Companies (BHC) Capital Expenditures (2016 - 2026)

Bausch Health Companies' Capital Expenditures history spans 18 years, with the latest figure at $109.0 million for Q1 2026.

On a quarterly basis, Capital Expenditures fell 5.22% to $109.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $391.0 million, a 5.68% increase, with the full-year FY2025 number at $397.0 million, up 17.8% from a year prior.
Capital Expenditures hit $109.0 million in Q1 2026 for Bausch Health Companies, up from $92.0 million in the prior quarter.
Over the last five years, Capital Expenditures for BHC hit a ceiling of $115.0 million in Q1 2025 and a floor of $28.0 million in Q2 2023.
Historically, Capital Expenditures has averaged $75.1 million across 5 years, with a median of $78.0 million in 2024.
Biggest five-year swings in Capital Expenditures: tumbled 46.15% in 2023 and later skyrocketed 178.57% in 2024.
Tracing BHC's Capital Expenditures over 5 years: stood at $66.0 million in 2022, then surged by 48.48% to $98.0 million in 2023, then grew by 8.16% to $106.0 million in 2024, then fell by 13.21% to $92.0 million in 2025, then rose by 18.48% to $109.0 million in 2026.
Business Quant data shows Capital Expenditures for BHC at $109.0 million in Q1 2026, $92.0 million in Q4 2025, and $91.0 million in Q3 2025.